Close Menu
    GCC TabloidGCC Tabloid
    • Automotive

      Jaguar Type 01 electric GT debuts with 1,030 PS

      October 7, 2026

      Japan new car sales rise 1.8% in first half of 2026

      July 2, 2026

      Porsche reveals bespoke 911 GT3 RS in Macadamiametallic

      May 18, 2026

      Mercedes-Benz unveils electric C-Class in Seoul

      April 21, 2026

      2027 Mercedes-Benz S-Class adds DIGITAL LIGHT micro-LEDs

      January 30, 2026
    • Business

      AfDB backs Morocco reforms and climate resilience with €434.4m

      November 14, 2026

      DP World partner ATI wins 25-year Manila port renewal

      November 13, 2026

      ADB flags $264 billion yearly ASEAN infrastructure gap

      November 12, 2026

      Amin Adam questions how Ghana will fund $10bn New Economy

      November 11, 2026

      Samsung Electronics cash assets hit record 214.8 trillion won

      November 9, 2026
    • Entertainment

      Sony confirms God of War trilogy remake and PS5 prequel

      February 13, 2026

      Apple Arcade adds Jeopardy and NFL games in September update

      August 19, 2025

      Moscow hosts historic 47th international festival

      April 19, 2025

      Legal action against ‘Ketamine Queen,’ doctors in Perry overdose

      August 17, 2024

      Web3 leader Immutable rolls out $50M gaming rewards initiative

      April 27, 2024
    • Health

      Ebola cases top 11,200 as Africa CDC warns of record outbreak

      November 16, 2026

      Yellow fever kills 18 across nine African nations, WHO says

      November 7, 2026

      Dengue kills 173 in October as Bangladesh toll climbs to 418

      November 2, 2026

      Ebola deaths in DR Congo reach 5,340, fatality rate at 51.6%

      November 2, 2026

      Ebola death toll in DR Congo nears 4,900 as cases pass 10,000

      October 28, 2026
    • Lifestyle

      Adidas unveils Treadflow, a treadmill shoe innovation

      August 24, 2025

      U.S. Polo Assn.’s fall-winter 2024 line inspired by Salt Lake City

      September 20, 2024

      JP Morgan funds Fresha with $31 million for AI and robotics growth

      August 23, 2024

      Adidas, Highsnobiety debut limited-edition sneakers

      January 6, 2024

      Unraveling Starbucks’ phenomenon as a worldwide coffee powerhouse

      September 1, 2023
    • Luxury

      Global luxury market contracts for first time since Great Recession

      November 18, 2024

      Uncover the allure of Rolex Deepsea – luxury awaits.

      April 10, 2024

      Beyond timekeeping to the prestige of the Rolex Day-Date

      March 2, 2024

      Rare uncut emerald dazzles at Sharjah show

      February 1, 2024

      Porsche and Frauscher launch the electric 850 Fantom Air

      October 17, 2023
    • News

      Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

      November 17, 2026

      Sheikh Mohamed and Ramos-Horta talk trade, energy and ASEAN

      November 16, 2026

      Sheikh Mohamed receives Arab League chief Nabil Fahmy

      November 14, 2026

      Three nations launch carbon crediting initiative at COP31

      November 13, 2026

      Nigeria and EU seal readmission deal after decade of talks

      November 12, 2026
    • Sports

      Africa hosts first Olympic event as Dakar 2026 YOG begins

      October 30, 2026

      Messi ends Argentina career with 207 caps and 125 goals

      September 1, 2026

      FIA President meets with Hungarian PM and Czech President

      July 28, 2026

      Portugal fall to Spain as Ronaldo legacy closes

      July 7, 2026

      Brazil exits World Cup after Norway Round of 16 victory

      July 6, 2026
    • Technology

      MEAPMP Launches: Revamped Independent Ad-Tech & Premium Media Buying Across MEA

      November 3, 2026

      Sam Altman calls UAE most forward-looking country on AI

      November 3, 2026

      Apple iPhone Duo sets a new benchmark for foldable design

      November 2, 2026

      Apple brings Touch and PROLED XDR display to MacBook Pro

      October 29, 2026

      Integrated Identity Enters Global Top 0.1% with Rare 100/100 Google PageSpeed

      October 29, 2026
    • Travel

      Over 9 million visitors lift Tunisia tourism income 3.4%

      November 17, 2026

      Damascus becomes Air Arabia Dammam’s second foreign route

      November 17, 2026

      Türkiye aims to rank sixth in global tourism revenue

      October 21, 2026

      Air Arabia launches Sharjah flights to Amman City Airport

      October 9, 2026

      Air Arabia resumes daily Ras Al Khaimah Kozhikode service

      October 7, 2026
    GCC TabloidGCC Tabloid
    Home » S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
    PR Newswire

    S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University

    September 20, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    SHANGHAI, Sept. 20, 2026 /PRNewswire/ — The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China is the China chapter of Science2Startup, an invitation-only symposium connecting top academic researchers with leading biotech investors. Ten standout biotech startup teams were selected from a highly competitive pool of applicants. They will refine their projects through a dedicated mentorship program and pitch to top global venture investors at an on-site event held at Westlake University on October 15.

    S2S was founded in 2018 by F-Prime, SV Health and Atlas Venture; RA Capital Management, Osage University Partners and 5AM Ventures have since joined the program. It connects therapeutics researchers at top academic and research institutions with leading biotech investors, pharma scouts, and industry executives. The program provides selected teams with mentorship and a platform to present novel, proprietary science with a path toward company formation and clinical development.

    This year’s S2S China drew enthusiastic participation from researchers and early-stage founders across China’s therapeutics research ecosystem. Following multiple rounds of rigorous review by an advisory group of experienced biopharma investors, the competition narrowed a large field of submissions to roughly 20 semifinalist teams, and ultimately selected ten standout teams to advance to the finals and present at the October 15 on-site pitch event.

    To help the participating teams connect effectively with the capital markets and strengthen their overall project framework, the finalists will take part in a dedicated mentorship program ahead of the event. Over the coming weeks, the teams will work alongside the S2S China Symposium advisory group, made up of experienced biotech investors and industry operators, to refine their scientific plans, sharpen their commercial narratives and polish their pitch content, raising the maturity of each project and laying a solid foundation for the on-site presentations and funding conversations that follow.

    This year’s S2S China Symposium is supported by prominent figures from academia and the global life sciences investment community, including Shi Yigong, President of Westlake University; Kan Chen, Partner and Healthcare Co-Lead at Qiming Venture Partners; and Josh Resnick, Partner at RA Capital Management. Their deep involvement underscores the symposium’s value as a bridge between China’s academic research ecosystem and the global biotech venture community, while continuing the model established by the original Science2Startup symposium.

    The event brings together a number of globally recognized institutions and biopharma leaders, forming a powerful supporting ecosystem. This year’s S2S China Symposium would not be possible without the strong support of leading companies across the industry, including our Platinum Sponsors Goodwin, Eli Lilly and Biocytogen, as well as Johnson & Johnson (Gold Sponsor) and Sanofi (Silver sponsor). The partnership of our sponsors reflects a shared commitment to advancing early-stage, academically-derived therapeutics innovation from China onto the global stage.

    Platinum Sponsors

    Goodwin is a global law firm at the intersection of capital and innovation, representing innovators and investors across healthcare, investment funds & capital, life sciences, private equity, real estate, and technology. With more than 2,800 professionals worldwide, Goodwin combines industry knowledge, legal excellence, and business advisory expertise to help clients navigate complex challenges and seize opportunities in a rapidly changing, technology-driven economy. We represent clients throughout the full corporate lifecycle, including company formation, financings, capital markets transactions, licensing and collaborations, M&A, regulatory matters, and exit strategies. Learn more: https://www.goodwinlaw.com/en

    Eli Lilly and Company is a global pharmaceutical leader headquartered in Indianapolis, Indiana, dedicated to discovering and delivering medicines that make life better for people around the world. With a deep commitment to scientific innovation, Lilly has been an active partner to the region’s biotech ecosystem, supporting early discovery through late-stage development across a range of therapeutic areas.

    Biocytogen is a global biotechnology company discovering and developing next-generation antibody therapeutics across multiple modalities. The company has built a broad portfolio of novel drug candidates spanning monoclonal and bispecific antibodies, ADCs, VHH-based therapeutics, and other antibody-based modalities, with multiple programs advancing into clinical development both internally and through global licensing partnerships. Powered by its proprietary RenMice® platforms and large-scale antibody discovery engine, Biocytogen has generated more than one million fully human antibody sequences across over 1,000 therapeutic targets and established partnerships with more than 455 biopharmaceutical companies worldwide.

    Gold Sponsor

    Johnson & Johnson is a global healthcare leader, headquartered in New Brunswick, New Jersey, committed to solving the toughest health challenges and transforming lives through research, development, manufacture and distribution of medicines and medical technologies. The company’s Innovative Medicine business advances breakthrough science and develops transformational treatments in areas like oncology, immunology, neuroscience, and cardiopulmonary. In MedTech, the company is focused on developing and delivering cardiovascular, surgery, and vision solutions.

    Silver Sponsor

    Sanofi is a global biopharmaceutical company headquartered in Paris, France, dedicated to pursuing scientific breakthroughs that improve people’s lives. The company focuses on immunology, oncology, neurology, rare diseases, ophthalmology and vaccines, and maintains a significant R&D and commercial presence in China, where it has long invested in partnerships with local academic and biotech innovators to expand its global pipeline.

    More information is available at s2schina.com/s2s/en.

    About Qiming Venture Partners

    Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

    Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 80 portfolio companies that have achieved unicorn or super unicorn status.

    Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.ai, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others.

    Cision View original content:https://www.prnewswire.co.uk/news-releases/s2s-china-announces-2026-finalists-ten-standout-teams-set-to-pitch-global-investors-at-westlake-university-302884010.html

    Related Posts

    Midea Showcases Full-Stack AIDC Cooling Solutions and Industry Insights at DCW Middle East 2026

    November 18, 2026

    Hansol Bio Expands Its Global Footprint with K-Beauty Manufacturing Expertise

    November 18, 2026

    Atain Appoints Jitendra Sindhwani (Jimpy) as Chief Executive Officer

    November 17, 2026

    Partnerships and Sponsorship Agreements Support Launch of Ajman Media Forum “THE SIGNAL 2026”

    November 17, 2026

    ALIF Holding Plans to Establish ALIF Terra for Arid-Land Agriculture and Land Rehabilitation

    November 17, 2026

    Getac’s New MX60 and MX60W Bring Mission-Critical Computing to Operators at the Tactical Edge

    November 17, 2026
    Latest News

    Over 9 million visitors lift Tunisia tourism income 3.4%

    November 17, 2026

    Damascus becomes Air Arabia Dammam’s second foreign route

    November 17, 2026

    Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

    November 17, 2026
    © 2026 GCC Tabloid | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.